97 related articles for article (PubMed ID: 1975274)
1. Synthesis and dopamine receptor affinities of 2-(4-fluoro-3- hydroxyphenyl)ethylamine and N-substituted derivatives.
Claudi F; Cardellini M; Cingolani GM; Piergentili A; Peruzzi G; Balduini W
J Med Chem; 1990 Sep; 33(9):2408-12. PubMed ID: 1975274
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and pharmacological characterization of 2-(4-chloro-3-hydroxyphenyl)ethylamine and N,N-dialkyl derivatives as dopamine receptor ligands.
Claudi F; Giorgioni G; Di Stefano A; Abbracchio MP; Paoletti AM; Balduini W
J Med Chem; 1992 Nov; 35(23):4408-14. PubMed ID: 1360027
[TBL] [Abstract][Full Text] [Related]
3. Structure-activity relationships of N-n-propyl-2-(4-fluoro-3-hydroxyphenyl)ethylamine derivatives as dopamine receptor ligands.
Claudi F; Giorgioni G; Di Stefano A; Renò F; Balduini W
Drug Des Discov; 1992; 9(2):155-66. PubMed ID: 1296798
[TBL] [Abstract][Full Text] [Related]
4. Activity of N-(2-phenylethyl)-N-n-propyl-2-(3-hydroxyphenyl) ethylamine derivatives as dopamine receptor ligands.
Claudi F; Cardellini M; Di Stefano A; Giorgioni G; Cantalamessa F; Renò F; Balduini W
Drug Des Discov; 1994 Feb; 11(2):115-25. PubMed ID: 7915549
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and dopamine receptors binding affinity of 2-(3-fluoro-4-hydroxyphenyl)ethylamine and its N-alkyl derivatives.
Cardellini M; Cingolani GM; Claudi F; Perlini V; Balduini W; Cattabeni F
Farmaco Sci; 1988 Jan; 43(1):49-59. PubMed ID: 2899520
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and dopamine receptor affinities of 6-amino-5,6,7,8-tetrahydroquinoline derivatives.
Claudi F; Cingolani GM; Giorgioni G; Cattabeni F; Cimino M; Di Luca M
Drug Des Deliv; 1989 Jun; 4(4):279-87. PubMed ID: 2570592
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and dopaminergic activity of some halogenated mono- and dihydroxylated 2-aminotetralins.
Weinstock J; Gaitanopoulos DE; Oh HJ; Pfeiffer FR; Karash CB; Venslavsky JW; Sarau HM; Flaim KE; Hieble JP; Kaiser C
J Med Chem; 1986 Sep; 29(9):1615-27. PubMed ID: 2875183
[TBL] [Abstract][Full Text] [Related]
8. Behavioural evidence for central D-2 dopamine receptor agonistic effect by some 2-(fluorohydroxyphenyl)ethylamines.
Ferrari F; Claudi F
Pharmacol Biochem Behav; 1991 Jan; 38(1):131-4. PubMed ID: 2017441
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and dopamine receptor binding of 4-(2-aminoethyl)-1H-pyrazole and its N,N-dialkyl derivatives.
Claudi F; Giorgioni G; Di Stefano A; Cagnotto A; Skorupska M
Drug Des Discov; 1993; 10(1):57-64. PubMed ID: 8104517
[TBL] [Abstract][Full Text] [Related]
10. Interaction of permanently charged chlorpromazine and dopamine analogs with the striatal D-1 dopaminergic receptor.
Wallace RA; Wallace L; Harrold M; Miller D; Uretsky NJ
Biochem Pharmacol; 1989 Jun; 38(12):2019-25. PubMed ID: 2525907
[TBL] [Abstract][Full Text] [Related]
11. Design, synthesis and properties of several heterocyclic dopaminergic ligands.
Kostić S; Soskić V; Joksimović J
Arzneimittelforschung; 1994 Jun; 44(6):697-702. PubMed ID: 7914413
[TBL] [Abstract][Full Text] [Related]
12. Pharmacology of binding of 3H-SCH-23390 to D-1 dopaminergic receptor sites in rat striatal tissue.
Faedda G; Kula NS; Baldessarini RJ
Biochem Pharmacol; 1989 Feb; 38(3):473-80. PubMed ID: 2563653
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and structural requirements of N-substituted norapomorphines for affinity and activity at dopamine D-1, D-2, and agonist receptor sites in rat brain.
Gao YG; Ram VJ; Campbell A; Kula NS; Baldessarini RJ; Neumeyer JL
J Med Chem; 1990 Jan; 33(1):39-44. PubMed ID: 2136919
[TBL] [Abstract][Full Text] [Related]
14. Structure-affinity relationship studies on D-2/5-HT1A receptor ligands. 4-(2-Heteroarylethyl)-1-arylpiperazines.
Dukić S; Vujović M; Soskić V; Joksimović J
Arzneimittelforschung; 1997 Mar; 47(3):239-43. PubMed ID: 9105540
[TBL] [Abstract][Full Text] [Related]
15. Potential antipsychotic agents. 9. Synthesis and stereoselective dopamine D-2 receptor blockade of a potent class of substituted (R)-N-[(1-benzyl-2-pyrrolidinyl)methyl]benzamides. Relations to other side chain congeners.
Högberg T; Ström P; de Paulis T; Stensland B; Csöregh I; Lundin K; Hall H; Ogren SO
J Med Chem; 1991 Mar; 34(3):948-55. PubMed ID: 1672158
[TBL] [Abstract][Full Text] [Related]
16. Pre- and postsynaptic dopaminergic activities of indolizidine and quinolizidine derivatives of 3-(3-hydroxyphenyl)-N-(n-propyl)piperidine (3-PPP). Further developments of a dopamine receptor model.
Liljefors T; Bøgesø KP; Hyttel J; Wikström H; Svensson K; Carlsson A
J Med Chem; 1990 Mar; 33(3):1015-22. PubMed ID: 1968512
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and receptor affinities of some conformationally restricted analogues of the dopamine D1 selective ligand (5R)-8-chloro-2,3,4,5-tetrahydro-3-methyl-5-phenyl- 1H-3-benzazepin-7-ol.
Berger JG; Chang WK; Clader JW; Hou D; Chipkin RE; McPhail AT
J Med Chem; 1989 Aug; 32(8):1913-21. PubMed ID: 2666667
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and evaluation of N,N-di-n-propyl-5,6,7,8-tetrahydro-1 H-benz[f]benzimidazol-6-yl-amine and related congeners as dopaminergic ligands.
Dragović D; Soskić V; Joksimović J
Pharmazie; 1995 Oct; 50(10):678-80. PubMed ID: 7501691
[TBL] [Abstract][Full Text] [Related]
19. N-substituted 1,2,3,4,4a,5,6,10b-octahydrobenzo[f]quinolines and 3-phenylpiperidines: effects on central dopamine and sigma receptors.
Wikström H; Andersson B; Elebring T; Svensson K; Carlsson A; Largent B
J Med Chem; 1987 Dec; 30(12):2169-74. PubMed ID: 2824773
[TBL] [Abstract][Full Text] [Related]
20. (+/-)-3-[4'-(N,N-dimethylamino)cinnamyl]benzazepine analogs: novel dopamine D1 receptor antagonists.
Shah JH; Kline RH; Geter-Douglass B; Izenwasser S; Witkin JM; Newman AH
J Med Chem; 1996 Aug; 39(17):3423-8. PubMed ID: 8765528
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
